A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.
Thierry Jahan, M.D. is the one of the region's foremost and highly regarded thoracic oncologists. Dr. Jahan has devoted his life to treating patients with lung cancer, mesothelioma and sarcoma. In addition to his keen clinical insight, Dr. Jahan is known by patients, their families and fellow clinicians for his sense of empathy and compassion. His commitment to wiping out lung cancer can be seen in the pins and ribbons that adorn his white coat, a message of hope he carries symbolically to patients as they battle a cruel disease.
Dr. Jahan received his M.D. from George Washington University. He completed his residency and an internal medicine fellowship at Cedars Sinai Medical Center in Los Angeles, followed by a fellowship in hematology and oncology at UCSF. In 1994, Dr. Jahan joined the UCSF faculty and later, with Dr. David M. Jablons, cofounded the Thoracic Oncology Program. Dr. Jahan currently holds the title of Associate Professor of Medicine at the UCSF School of Medicine.
Dr. Jahan has been the recipient of numerous awards including the Medical House Staff Outstanding Teacher Award and Friend of the Palliative Care Service Award. He is also a member of numerous professional organizations, including the American College of Physicians, American Society of Clinical Oncology (ASCO), and International Association for the Study of Lung Cancer (IASLC) and the Association of Northern California Oncologists.
Dr. Jahan has authored or co-authored numerous peer-reviewed articles, book chapters and research abstracts and lectured nationally and internationally on lung cancer and mesothelioma. The San Francisco Chronicle, Time Magazine and KPIX in San Francisco have each sought out his insights and observations on the clinical and human side of battling serious life-threatening cancers.
Dr. Jahan is Principal Investigator on numerous thoracic oncology clinical trials. He has a particular interest in testing target therapies in non-small cell lung cancer malignant mesothelioma as either single agents or in combination with chemotherapy and/or radiation.
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team, led by UCSF thoracic surgeons David M. Jablons, M.D. and Michael Mann, M.D., demonstrated that a 14-gene prognostic molecular assay better predicted the likelihood of death in early-stage lung cancer patients versus conventional staging guidelines. Johannes Kratz, M.D., a former surgical resident in the Thoracic Oncology Laboratory, helped spearhead the development of the assay and was lead author of a paper published in The Lancet discussing the results. John Minna, M.D.", Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology at UT Southwestern lauded the results, stating that the assay was "head and shoulders" above the rest and ready for "prime time" clinical use.
Every July, the Thoracic Oncology Program provides a summary update of its accomplishments during the prior twelve (12) months. The program continues to grow and innovate. General Thoracic Surgery continues to innovate and expand the number of minimally invasive procedures it performs. The program's status as the busiest on the West Coast and the best place to refer complex and challenging cases continues. With a strong multidisciplinary team including UCSF Medical Oncology, Radiation Oncology and Pulmonology, the program continues to offer state-of-the-art care for the region and beyond.
Thierry Jahan, M.D., an Associate Professor of Medicine Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology, is one of four recipients of the 2010 UCSF Medical Center Exceptional Physician Award, an honor recognizing dedication to outstanding patient care and to the instiutions' values of Professionalism, Respect, Integrity, Diversity and Excellence. One of the region's most highly regarded thoracic oncologists and sarcoma specialists.
The Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology has been created in the Department of Surgery in honor of Thierry Jahan, M.D., an Associate Professor of Medicine at UCSF, who will occupy the Chair as its first recipient. Dr. Jahan is the one of the region's most highly regarded thoracic oncologists and sarcoma specialists, known among patients, their families, and colleagues for his deep sense of empathy and compassion. Dr. Jahan co-founded the multidisciplinary Thoracic Oncology Program with David Jablons M.D.. On July 9, 2009, there was a celebration held at the Kalmonovitz Library at UCSF to honor Dr. Jahan and his appointment to the newly created Chair.
"Soft tissue sarcomas are extraordinarily heterogeneous, so experience is particularly important when deciding among treatment options," says medical oncologist Thierry M. Jahan, M.D. (pictured right). At UCSF, referring physicians typically send patients with painful, growing soft tissue masses to orthopedic surgeon Richard J. O'Donnell, M.D., and general surgeon Eric K. Nakakura, M.D., Ph.D, (pictured left). If their initial examination convinces them that there is a sarcoma concern, they move on to a staging workup that includes various imaging modalities and, eventually, either a needle or incisional biopsy...."